跳至主要内容
临床试验/DRKS00029508
DRKS00029508尚未招募不适用

Cognitive function and psychological capability in Post-Covid-19 syndrome

Klinik für Allgemeine Psychiatrie, Universitätsklinikum Heidelberg0 个研究点目标入组 128 人开始时间: 2022年7月14日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
128

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Ability to provide informed consent, age = 18 years, history of SARS-CoV-2 infection.
  • Group 1: new or worsened psychiatric symptoms concerning affectivity, energy levels and tiredness, cognition or anxiety and stress related problems that have started after SARS-CoV-2 infection and are persistent on the day of examination, but no shorter than 12 weeks (so called post-covid-syndrom).
  • Group 2: no residual symptoms of after SARS-CoV-2 infection.

排除标准

  • 1. unable to provide informed consent
  • 2. acute, severe somatic or psychiatric illnesses, such as:
  • psychiatric:
  • - acute psychosis
  • - acute suicidal ideation
  • - acute mania
  • - acute intoxication
  • - severe anxiety/OCD/depressive symptoms impeding the examination
  • -acute neurologic or somatic illnesses that require medical attention such as acute infections, pain or injuries
  • -persistent or chronic conditions that may impede the examination (particularly sensory or motor deficits)

研究者

发起方
Klinik für Allgemeine Psychiatrie, Universitätsklinikum Heidelberg

相似试验